Odyssey Therapeutics, Inc 10-Q for FY2026 Q2
Odyssey Therapeutics, Inc. (ODTX)
10-Q
2026-08-06
For: 2026-06-30
View Original
Added on
August 06, 2026
About this 10-Q
Odyssey Therapeutics, Inc filed this 10-Q on August 6, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $959K a year earlier
- Net loss
- $52.79M
- compared with a net loss of $41.24M a year earlier
- Diluted EPS
- -$1.74
- compared with -$29.54 a year earlier